Arcus Biosciences, Inc.

Arcus Biosciences is a U.S. clinical-stage biopharmaceutical company developing differentiated drug candidates for cancer and immune-mediated diseases. Its research combines medicinal chemistry, established disease biology and selected antibody-based capabilities, with an emphasis on molecules and treatment combinations that could improve patient outcomes. Arcus is headquartered in Hayward, California, and its shares trade on the New York Stock Exchange under RCUS. The company conducts clinical and discovery-stage research in oncology and has expanded work toward immune diseases. This concise profile emphasizes the issuer's scientific focus and identity.